Medicus Pharma Ltd. logo

Medicus Pharma Ltd.

Canonical company identity and public leadership record.

NASDAQ: MDCXUS

  • Source reported. 23 claims from 3 sources.
  • Not claimed by the company.
  • Eval: not assessed.
Board
4 directorsAlpha calculation. Published seats
Independence
4 of 4Alpha calculation
Committees
5
Evidence
3 sources23 published claims
Last reviewed
Freshness: current
Open conflicts
0None open
Alpha EvalNot assessed. No Eval is published for this company.

Leadership

2 claims
Leadership
PersonRoleSinceStatusEvidence
Andrew SmithChief Operating OfficerCurrentSource reportedE3

Stated in the record as Andrew Smith: Chief Operating Officer

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:11

Report an error
Carolyn BonnerPresident and Chief Financial OfficerCurrentSource reportedE4

Stated in the record as Carolyn Bonner: President and Chief Financial Officer

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:12

Report an error

Board

7 claims
Board of directors
DirectorStatusSinceCommitteesEvidence
Barry FishmanIndependentAudit; Audit; Compensation; CompensationSource reportedE2

Stated in the record as Barry Fishman: Director, Audit; Compensation

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:6

Report an error
Frank LavelleIndependentAudit; Audit; Compensation · Chair; Compensation, chairSource reportedE2

Stated in the record as Frank Lavelle: Director, Audit; Compensation · Chair

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:7

Report an error
Robert J. CiaruffoliIndependentAudit, chair; Audit · Chair; Compensation; CompensationSource reportedE2

Stated in the record as Robert J. Ciaruffoli: Director, Audit · Chair; Compensation

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:9

Report an error
William L. AshtonIndependentNone publishedSource reportedE2

Stated in the record as William L. Ashton: Director

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:10

Report an error
Ajay RajuIndependentNot publishedNone publishedSource reportedE2

Stated in the record as Ajay Raju: Director

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:5

Report an error
Dr. Sara R. MayIndependence not publishedNot publishedAudit; CompensationSource reportedE5

Stated in the record as Audit: Chair Robert J. Ciaruffoli; Members Robert J. Ciaruffoli (Chair); Barry Fishman; Dr. Sara R. May; Frank Lavelle

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_record:13

Report an error
Hon. Cathy McMorris RodgersIndependentNot publishedNone publishedSource reportedE2

Stated in the record as Hon. Cathy McMorris Rodgers: Director

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:leadership_role:8

Report an error

Committees

9 claims
Committee risk allocation
CommitteeChairMembersRisks assignedEvidence
AuditRobert J. CiaruffoliRobert J. Ciaruffoli, Barry Fishman, Dr. Sara R. May, Frank LavelleNot described in the published record
Audit · Chair; CompensationNot publishedRobert J. CiaruffoliNot described in the published record
Audit; CompensationNot publishedBarry FishmanNot described in the published record
Audit; Compensation · ChairNot publishedFrank LavelleNot described in the published record
CompensationFrank LavelleFrank Lavelle, Barry Fishman, Dr. Sara R. May, Robert J. CiaruffoliNot described in the published recordSource reportedE5

Stated in the record as Compensation: Chair Frank Lavelle; Members Frank Lavelle (Chair); Barry Fishman; Dr. Sara R. May; Robert J. Ciaruffoli

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_record:18

Report an error
Committees and risk ownership: further claims
FactStated valueEvidence
Committee appointmentRobert J. Ciaruffoli: chair, AuditSource reportedE5

Stated in the record as Robert J. Ciaruffoli: chair, Audit

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:14

Report an error
Committee appointmentBarry Fishman: member, AuditSource reportedE5

Stated in the record as Barry Fishman: member, Audit

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:15

Report an error
Committee appointmentDr. Sara R. May: member, AuditSource reportedE5

Stated in the record as Dr. Sara R. May: member, Audit

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:16

Report an error
Committee appointmentFrank Lavelle: member, AuditSource reportedE5

Stated in the record as Frank Lavelle: member, Audit

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:17

Report an error
Committee appointmentFrank Lavelle: chair, CompensationSource reportedE5

Stated in the record as Frank Lavelle: chair, Compensation

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:19

Report an error
Committee appointmentBarry Fishman: member, CompensationSource reportedE5

Stated in the record as Barry Fishman: member, Compensation

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:20

Report an error
Committee appointmentDr. Sara R. May: member, CompensationSource reportedE5

Stated in the record as Dr. Sara R. May: member, Compensation

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:21

Report an error
Committee appointmentRobert J. Ciaruffoli: member, CompensationSource reportedE5

Stated in the record as Robert J. Ciaruffoli: member, Compensation

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:committee_appointment:22

Report an error

Financial context

2 claims
Financials and market context
FactStated valueEvidence
Security listingMDCX (NASDAQ)Source reportedE1

Stated in the record as MDCX (NASDAQ)

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:security_listing:23

Report an error
Security listingMDCXW (NASDAQ)Source reportedE1

Stated in the record as MDCXW (NASDAQ)

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:security_listing:24

Report an error

Other published claims

3 claims
Other published claims
FactStated valueEvidence
Legal nameMedicus Pharma Ltd.Source reportedE1

Stated in the record as Medicus Pharma Ltd.

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:legal_name:1

Report an error
Entity statusPublic listing publishedSource reportedE1

Stated in the record as Public listing published

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:entity_status:3

Report an error
Published factUSSource reportedE1

Stated in the record as US

Claim ID alpha:claim:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc:published_fact:4

Report an error

Evidence

5 evidence records
Evidence ledger
RefSourceAuthoritySource dateRetrievedRightsCited by
E1Alpha canonical company public projectionCanonical identityOpen webNot recordedRights not recorded, link only5 claims
E2Medicus Pharma Ltd. DEF 14A 2025-06-30SEC proxyAuthoritative, regulatory filingRights not recorded, link only6 claims
E3MDCX DEF 14A executive officersSEC filingAuthoritative, regulatory filingRights not recorded, link only1 claim
E4MDCX DEF 14A executive officersSEC filingAuthoritative, regulatory filingRights not recorded, link only1 claim

No evidence record is pinned or signed yet.

Not yet in this record

These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.

  • Control and voting
  • Authority
  • Governance
  • Risk
  • AI oversight
  • Compensation

Index memberships

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Coverage states the record reports (12)
Corporate structure
Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
Ownership
Not reviewed. Ownership and voting power determine who can influence the board.
Financials
Not reviewed. Governance-relevant financial context frames capital and audit decisions.
Compensation
Not reviewed. Pay design shows how incentives are governed.
Governance
Not reviewed. Governing documents and provisions set the rules of the enterprise.
Shareholder governance
Not reviewed. Meeting and vote records show shareholder dissent and support.
Audit
Not reviewed. Auditor, controls and restatements show assurance over reporting.
Legal
Not reviewed. Material legal and regulatory matters show enforcement exposure.
Risk
Not reviewed. Risk ownership links the board, committees, executives and controls.
Cyber
Not reviewed. Cyber and data governance is a disclosed oversight domain.
AI governance
Not reviewed. AI oversight is a differentiated Alpha governance domain.
Markets external
Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

History

Version public-1

Published .

  1. Executive appointed. Andrew Smith executive of Medicus Pharma Ltd., effective 4 May 2026.Effective . Recorded .
  2. CFO role recorded. Carolyn Bonner executive of Medicus Pharma Ltd., effective 4 May 2026.Effective . Recorded .
  3. Director appointed. Barry Fishman seat on Medicus Pharma Ltd., effective 2023.Effective . Recorded .
  4. Director appointed. Frank Lavelle seat on Medicus Pharma Ltd., effective 2023.Effective . Recorded .
  5. Director appointed. Robert J. Ciaruffoli seat on Medicus Pharma Ltd., effective 2023.Effective . Recorded .
  6. Director appointed. William L. Ashton seat on Medicus Pharma Ltd., effective 2023.Effective . Recorded .
  7. Committee created. Audit · Chair; Compensation committee of Medicus Pharma Ltd., effective 2023.Effective . Recorded .
  8. Committee member added. Robert J. Ciaruffoli member of Audit · Chair; Compensation, effective 2023.Effective . Recorded .
  9. Committee created. Audit; Compensation committee of Medicus Pharma Ltd., effective 2023.Effective . Recorded .
  10. Committee member added. Barry Fishman member of Audit; Compensation, effective 2023.Effective . Recorded .
  11. Committee created. Audit; Compensation · Chair committee of Medicus Pharma Ltd., effective 2023.Effective . Recorded .
  12. Committee member added. Frank Lavelle member of Audit; Compensation · Chair, effective 2023.Effective . Recorded .

About this record

Alpha ID
alpha:company:8d2cf3dd-e9da-4a61-8b5a-3ca1c95a88bc
Version
public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
Identity
Not claimed
Evidence
Source reported
Evaluation
Not assessed
Monitoring
Not monitored yet
Authority
Not published
Freshness
Current
Integrity
Not signed yet
Basis
Published company record built from public sources
Never published
Private company data: deployments, authority grants, TrustChecks, receipts, telemetry

The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.